Veozah (fezolinetant) Updated with Warning on Rare Serious Liver Injury

By Richard Waithe, PharmD
Veozah (fezolinetant) Updated with Warning on Rare Serious Liver Injury
Drug Safety & RecallsWomen's Health

Related Articles

Lilly Launches Zepbound KwikPen: A Multi-Dose Monthly Option for Weight Management
Clinical Practice

Lilly Launches Zepbound KwikPen: A Multi-Dose Monthly Option for Weight Management

FDA Approves YUVEZZI: First Dual-Agent Eye Drop for Age-Related Near Vision Loss
Clinical Practice

FDA Approves YUVEZZI: First Dual-Agent Eye Drop for Age-Related Near Vision Loss

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know
Clinical Practice

Gabapentin Linked to Dementia Risk: What Pharmacists Need to Know